RxDoctor Payments Data
★ My doctorsLook up a doctor →

Mark Lobanoff, MD

Ophthalmology · St Louis Park, MNNPI 1205870045

Payments from drug & device makers

What this record shows

This record is dominated by other: $4,125,000 of the $6,311,244 with a category attached, or 65.4%. Alcon Research LLC accounts for 67.1% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2024 at $4,573,429 and has fallen 95.5% since, to $204,442 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,311,244in general payments, 2019–2025

Across 436 payments — averaging $14,475 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$4.2M
  • Alcon$2M
  • Bausch & Lomb Americas Inc.$97K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$6K
  • Carl Zeiss Meditec USA, Inc.$369
  • Glaukos Corporation$314
  • plus $1K from 14 others
$768,942in research payments, 2019–2025

Across 76 payments — averaging $10,118 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$503K
  • Bausch Health US, LLC$150K
  • Bausch & Lomb Americas Inc.$116K

What the payments were for

  • Royalty or licence$1,831,19029%
  • Consulting fees$298,2035%
  • Speaking & faculty fees$11,3860%
  • Travel & lodging$36,5781%
  • Food & beverage$8,8520%
  • Gifts$370%
  • Other$4,125,00065%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alcon Research LLC12$4,234,606
Alcon310$1,971,443
Bausch & Lomb Americas Inc.59$97,184
Bausch & Lomb, A Division Of Bausch Health US, LLC6$6,143
Carl Zeiss Meditec USA, Inc.2$369
Glaukos Corporation10$314
Ziemer USA3$293
Rxsight Inc6$163
The Cameron-ehlen Group, Inc.6$145
Carl Zeiss Meditec, Inc.2$93
Oyster Point Pharma, Inc.5$86
Novartis3$73
Haag-streit USA, Inc.1$63
AbbVie2$56
Staar Surgical Company2$51
Harrow Eye, LLC2$49
Sun Pharmaceutical Industries Inc.2$46
Biotissue Holdings Inc.1$35
Carl Zeiss Meditec AG1$19
Lensar, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,311,244 in reported general payments places this provider in the 95th percentile of 330 ophthalmology providers in Minnesota.

See all ophthalmology providers in Minnesota →

Medicare billing

Part B allowed, 2024
$98,646
Medicare patients
81
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in St Louis Park

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →